At­ul Gawande takes aim at surg­ing pre­scrip­tion drug costs as chief of cryp­tic Buf­fett-Be­zos-Di­mon ven­ture now chris­tened 'Haven'

Ear­ly last year, when the pow­er­ful trio of War­ren Buf­fett (Berk­shire Hath­away), Jamie Di­mon (JP­Mor­gan Chase) and Jeff Be­zos (Ama­zon) joined forces to fix the “bro­ken” US health­care sys­tem, the in­dus­try shud­dered with a mix­ture of fear and an­tic­i­pa­tion. Months lat­er, well re­gard­ed In­di­an-Amer­i­can doc­tor, au­thor and re­nais­sance man At­ul Gawande en­tered the fold as the ven­ture’s chief — but de­tails on how the en­ti­ty in­tend­ed to reach its goal re­mained scant. On Wednes­day, the non-prof­it ven­ture was of­fi­cial­ly chris­tened “Haven,” and its plans to dis­rupt the sta­tus quo were fleshed out, al­beit min­i­mal­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.